What type of genital ulcers in a patient with chancroid can serve as an entry point for Human Immunodeficiency Virus (HIV) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chancroid Ulcers as HIV Entry Points

All genital ulcers caused by chancroid—the painful, necrotizing ulcerations characteristic of Haemophilus ducreyi infection—serve as entry points for HIV transmission. 1

Understanding the HIV-Chancroid Connection

The CDC explicitly states that chancroid has been "well established as a co-factor for HIV transmission" with high rates of HIV infection reported among chancroid patients in both the United States and internationally. 1 This relationship is bidirectional:

  • Any disruption of the genital epithelium created by chancroid ulcers facilitates HIV entry by breaching the protective mucosal barrier. 1
  • The ulcers themselves—whether single or multiple, regardless of size—all represent potential portals for viral transmission. 1
  • Both the primary painful ulcers and associated suppurative inguinal lymphadenopathy (buboes) contribute to increased HIV susceptibility. 1

Clinical Implications for HIV Risk

The typical presentation of chancroid includes:

  • One or more painful genital ulcers with ragged, undermined edges and purulent bases—all of which compromise mucosal integrity. 1
  • Tender inguinal adenopathy occurring in one-third of patients, which when suppurative is almost pathognomonic for chancroid. 1
  • The combination of genital ulceration with regional lymphadenopathy creates multiple sites of potential HIV exposure. 1

Critical Management Priorities

HIV testing must be performed at the time of chancroid diagnosis because of this established transmission risk. 1 The CDC recommends:

  • Immediate HIV testing at initial presentation with chancroid. 1
  • Repeat HIV testing at 3 months if the initial test is negative, given the window period for seroconversion. 1, 2
  • Recognition that genital ulcers may be markers of high-risk sexual behavior beyond the direct biological facilitation of HIV transmission. 3

Treatment Urgency

Early treatment reduces both HIV transmission risk and onward spread of chancroid itself. 4 Single-dose regimens (azithromycin 1 g orally or ceftriaxone 250 mg IM) are preferred because they:

  • Ensure compliance at first presentation. 1, 5, 6
  • Rapidly initiate ulcer healing, reducing the duration of HIV vulnerability. 1, 5
  • Minimize the window for HIV transmission to sexual partners. 4

Special Considerations

HIV-positive patients with chancroid face bidirectional complications:

  • Chancroid ulcers heal more slowly in HIV-infected individuals. 1, 2
  • Treatment failure rates are higher among HIV-positive patients. 1, 2
  • These patients may require prolonged therapy courses beyond standard regimens. 1, 2
  • The CDC recommends the 7-day erythromycin regimen (500 mg orally four times daily) for HIV-infected patients with close follow-up. 1, 5

Partner Management

All sexual contacts within 10 days before symptom onset must be treated empirically, regardless of symptoms, to prevent reinfection and limit onward transmission of both chancroid and HIV. 1, 5, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Non-Healing Genital Ulcer After Antibiotic Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Approach to the patient with genital ulcer disease.

The Medical clinics of North America, 1990

Research

Treatment of chancroid in resource-poor countries.

Expert review of anti-infective therapy, 2005

Guideline

Management of Chancroid

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Female Sex Workers with Suspected Sexually Transmitted Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.